Effects of Metabolic Syndrome on Pregnancy Outcomes in Women Without Polycystic Ovary Syndrome

Overview

Journal J Endocr Soc

Specialty Endocrinology

Date 2024 Sep 3

PMID 39224458

Authors

Siyuan Li

Shuxin Ma

Xiangyi Yao

Peihao Liu

Affiliations

Soon will be listed here.

Abstract

Context: Metabolic syndrome (MetS) is a cluster of metabolic risk factors that predict cardiovascular disease. Previous studies suggested that MetS impaired clinical outcomes in women with polycystic ovary syndrome (PCOS) undergoing in vitro fertilization (IVF).

Objective: To evaluate the effects of MetS on IVF/intracytoplasmic sperm injection (ICSI) outcomes in women without PCOS.

Methods: This retrospective study collected 8539 eligible women without PCOS who came for their first cycle of IVF/ICSI to the Institute of Women, Children and Reproductive Health, Shandong University, from 2017 to 2020, including 1147 subjects in the MetS group and 7392 in the control group. The primary outcome was live birth. Secondary outcomes included other pregnancy outcomes and the risk of maternal and neonatal complications.

Results: Women in the MetS group had a lower live birth rate (50.6% vs 54.9%, adjusted odds ratio [aOR] 0.87, 95% CI 0.75-1.00, = .045) and higher risks of late miscarriage (5.8% vs 3.3%, aOR 1.52, 95% CI 1.02-2.27, = .041), gestational diabetes mellitus (13.7% vs 7.0%, aOR 1.84, 95% CI 1.30-2.60, = .001), hypertensive disorder of pregnancy (7.8% vs 3.5%, aOR 1.79, 95% CI 1.14-2.83, = .012), and preterm birth (9.0% vs 4.4%, aOR 2.03, 95% CI 1.33-3.08, = .001). Singleton newborns in the MetS group were at higher risk of large for gestational age (33.3% vs 20.5%, aOR 1.66, 95% CI (1.31-2.13), < .001) but at lower risk of small for gestational age (2.7% vs 6.2%, aOR 0.48, 95% CI 0.25-0.90, = .023).

Conclusion: MetS was associated with adverse IVF/ICSI outcomes in women without PCOS.

Citing Articles

Effects of Metabolic Syndrome on Pregnancy Outcomes in Women Without Polycystic Ovary Syndrome.

Li S, Ma S, Yao X, Liu P J Endocr Soc. 2024; 8(10):bvae143.

PMID: 39224458 PMC: 11368129. DOI: 10.1210/jendso/bvae143.

References

Gierach M, Gierach J, Ewertowska M, Arndt A, Junik R . Correlation between Body Mass Index and Waist Circumference in Patients with Metabolic Syndrome. ISRN Endocrinol. 2014; 2014:514589. PMC: 3960736. DOI: 10.1155/2014/514589. View

Guo X, Li Z, Guo L, Zheng L, Yu S, Yang H . An update on overweight and obesity in rural Northeast China: from lifestyle risk factors to cardiometabolic comorbidities. BMC Public Health. 2014; 14:1046. PMC: 4198624. DOI: 10.1186/1471-2458-14-1046. View

Yao F, Bo Y, Zhao L, Li Y, Ju L, Fang H . Prevalence and Influencing Factors of Metabolic Syndrome among Adults in China from 2015 to 2017. Nutrients. 2021; 13(12). PMC: 8705649. DOI: 10.3390/nu13124475. View

Manneras-Holm L, Leonhardt H, Kullberg J, Jennische E, Oden A, Holm G . Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. J Clin Endocrinol Metab. 2010; 96(2):E304-11. DOI: 10.1210/jc.2010-1290. View

Jayasinghe I, Agampodi T, Dissanayake A, Agampodi S . Early pregnancy metabolic syndrome and risk for adverse pregnancy outcomes: findings from Rajarata Pregnancy Cohort (RaPCo) in Sri Lanka. BMC Pregnancy Childbirth. 2023; 23(1):231. PMC: 10074348. DOI: 10.1186/s12884-023-05548-y. View

Liu Z, Cong J, Liu X, Zhao H, Lai S, He S . Dyslipidemia Is Negatively Associated With the Cumulative Live-Birth Rate in Patients Without PCOS Following IVF/ICSI. Front Physiol. 2021; 12:713356. PMC: 8414789. DOI: 10.3389/fphys.2021.713356. View

Broughton D, Moley K . Obesity and female infertility: potential mediators of obesity's impact. Fertil Steril. 2017; 107(4):840-847. DOI: 10.1016/j.fertnstert.2017.01.017. View

Chu S, Callaghan W, Kim S, Schmid C, Lau J, England L . Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care. 2007; 30(8):2070-6. DOI: 10.2337/dc06-2559a. View

Grieger J, Bianco-Miotto T, Grzeskowiak L, Leemaqz S, Poston L, McCowan L . Metabolic syndrome in pregnancy and risk for adverse pregnancy outcomes: A prospective cohort of nulliparous women. PLoS Med. 2018; 15(12):e1002710. PMC: 6279018. DOI: 10.1371/journal.pmed.1002710. View

10.

Eckel R, Alberti K, Grundy S, Zimmet P . The metabolic syndrome. Lancet. 2010; 375(9710):181-3. DOI: 10.1016/S0140-6736(09)61794-3. View

11.

Fernandez A, Dauden E, Gerdes S, Lebwohl M, Menter M, Leonardi C . Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5-year data from reSURFACE 1 and reSURFACE 2. J Eur Acad Dermatol Venereol. 2022; 36(10):1774-1783. PMC: 9545614. DOI: 10.1111/jdv.18167. View

12.

Saklayen M . The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018; 20(2):12. PMC: 5866840. DOI: 10.1007/s11906-018-0812-z. View

13.

Chatzi L, Plana E, Daraki V, Karakosta P, Alegkakis D, Tsatsanis C . Metabolic syndrome in early pregnancy and risk of preterm birth. Am J Epidemiol. 2009; 170(7):829-36. DOI: 10.1093/aje/kwp211. View

14.

Shen J, Poole J, Topel M, Bidulescu A, Morris A, Patel R . Subclinical Vascular Dysfunction Associated with Metabolic Syndrome in African Americans and Whites. J Clin Endocrinol Metab. 2015; 100(11):4231-9. PMC: 4702465. DOI: 10.1210/JC.2014-4344. View

15.

Fowden A . Insulin deficiency: effects on fetal growth and development. J Paediatr Child Health. 1993; 29(1):6-11. DOI: 10.1111/j.1440-1754.1993.tb00428.x. View

16.

Li S, Ma S, Yao X, Liu P . Effects of Metabolic Syndrome on Pregnancy Outcomes in Women Without Polycystic Ovary Syndrome. J Endocr Soc. 2024; 8(10):bvae143. PMC: 11368129. DOI: 10.1210/jendso/bvae143. View

17.

Chen K, Lin S, Lee C, Wu H, Kuo C, Kuo H . Maternal Plasma Lipids During Pregnancy, Insulin-like Growth Factor-1, and Excess Fetal Growth. J Clin Endocrinol Metab. 2021; 106(9):e3461-e3472. DOI: 10.1210/clinem/dgab364. View

18.

Gurka M, Filipp S, Musani S, Sims M, DeBoer M . Use of BMI as the marker of adiposity in a metabolic syndrome severity score: Derivation and validation in predicting long-term disease outcomes. Metabolism. 2018; 83:68-74. PMC: 5960618. DOI: 10.1016/j.metabol.2018.01.015. View

19.

Chang H, Xie L, Ge H, Wu Q, Wen Y, Zhang D . Effects of hyperhomocysteinaemia and metabolic syndrome on reproduction in women with polycystic ovary syndrome: a secondary analysis. Reprod Biomed Online. 2019; 38(6):990-998. DOI: 10.1016/j.rbmo.2018.12.046. View

20.

Shah D, Missmer S, Berry K, Racowsky C, Ginsburg E . Effect of obesity on oocyte and embryo quality in women undergoing in vitro fertilization. Obstet Gynecol. 2011; 118(1):63-70. DOI: 10.1097/AOG.0b013e31821fd360. View